Präoperative kardiovaskuläre Risikoeinschätzung - Therapie

Die Indikationen für perioperative diagnostische, medikamentöse, interventionelle und operative Maßnahmen sind im Allgemeinen identisch mit denen ohne eine nachfolgende Operation. Die zeitliche Abfolge ist jedoch oft abhängig von zusätzlichen Faktoren wie beispielsweise der Dringlichkeit des operativen Eingriffs und erfordert eine gute Kommunikation und Zusammenarbeit zwischen Chirurgen, Anästhesisten und Internisten.

Literatur

• 1 Foster E D, Davis K B, Carpenter J A, Abele S, Fray D. Risk of noncardiac operation in patients with defined coronary disease: The Coronary Artery Surgery Study (CASS) registry experience.  Ann Thorac Surg. 1986;  41 42-50
• 2 Eagle K A, Rihal C S, Mickel M C, Holmes D R, Foster E D, Gersh B J. Cardiac risk of noncardiac surgery. influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program: Coronary Artery Surgery Study.  Circulation. 1997;  96 1882-1887
• 3 ACC/AHA Guidelines for perioperative cardiovascular evaluation for noncardiac surgery . Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery.  Circulation. 1996;  93 1278-1317
• 4 ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery . Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).  Circulation. 2002;  105 1257-1267
• 5 Moses J W, Leon M B, Popma J J. et al . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.  N Engl J Med. 2003;  349 1315-1323
• 6 Mangano D T, Layug E L, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.  N Engl J Med. 1996;  335 1713-1720
• 7 Poldermans D, Boersma E, Bax J J. et al . The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.  N Engl J Med. 1999;  341 1789-1794
• 8 Boersma E, Poldermans D, Bax J J. et al . Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.  JAMA. 2001;  285 1865-1873
• 9 Poldermans D, Bax J J, Kertai M D. et al . Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery.  Circulation. 2003;  107 1848-1851
• 10 Böhm M. Perioperatives Risiko und präoperative Vorbereitung des herzinsuffizienten Patienten zur nichtkardialen Operation.  Internist. 2000;  41 283-291
• 11 Packer M, Bristow M R, Cohn J N. et al . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group.  N Engl J Med. 1996;  334 1349-1355
• 12 The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) . A randomised trial.  Lancet. 1999;  353 9-13
• 13 Effect of metoprolol CR/XL in chronic heart failure . Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).  Lancet. 1999;  353 2001-2007
• 14 Packer M, Coats A J, Fowler M B. et al . Effect of carvedilol on survival in severe chronic heart failure.  N Engl J Med. 2001;  344 1651-1658
• 15 Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).  Z Kardiol. 2003;  92 668-676
• 16 The Digitalis Investigation Group . The effect of digoxin on mortality and morbidity in patients with heart failure.  N Engl J Med. 1997;  336 525-533
• 17 Tauke J, Goldstein S, Gheorghiade M. Digoxin for chronic heart failure: a reviwe of the randomized controlled trials with special attention to the PROVED and RADIANCE Trials.  Prog Cardiovasc Res. 1994;  37 49-58
• 18 Jung J, Böhm M. Vorhofflimmern - Therapie.  Dtsch Med Wochenschr. 2001;  126 1472-1475
• 19 Cremers B, Böhm M. Kalziumantagonisten in der Therapie der Herzinsuffizienz. Stuttgart, New York: Schattauer In: Kalziumantagonisten-Handbuch. Bönner G, Dominiak P, eds 2002: 467-507
• 20 Kalman J M, Munawar M, Howes G L. et al . Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation.  Ann Thorac Surg. 1995;  60 1709-1715
• 21 Lee T H, Marcantonio E R, Mangione C M. et al . Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.  Circulation. 1999;  100 1043-1049
• 22 Fleisher L A, Eagle K A. Clinical practice. Lowering cardiac risk in noncardiac surgery.  N Engl J Med. 2001;  345 1677-1682